Farnesyltransferase inhibitors and anti-Ras therapy-Reference-Cited by-同舟云学术

Farnesyltransferase inhibitors and anti-Ras therapy

Published:1996-02 Issue:1 Volume:38 Page:75-83
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Tr

Author:

Gibbs Jackson B.,Kohl Nancy E.,Koblan Kenneth S.,Omer Charles A.,Sepp-Lorenzino Laura,Rosen Neal,Anthony Neville J.,Conner Michael W.,deSolms S. Jane,Williams Theresa M.,Graham Samuel L.,Hartman George D.,Oliff Allen

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF01803786.pdf

Reference29 articles.

1. Lowy DR, Willumsen BM: Function and regulation of Ras. Annu Rev Biochem 62:851–891, 1993

2. McCormick F: Activators and effectors ofras p21 proteins. Curr Opin Genetics Devel 4:71–76, 1994

3. Prendergast GC, Gibbs JB: Pathways of Ras function. Adv Cancer Res 62:19–64, 1993

4. Clarke S: Protein isoprenylation and methylation at carboxyl-terminal cysteine residues. Annu Rev Biochem 61:355–386, 1992

5. Cox AD, Der CJ: Protein prenylation: more than just glue? Curr Opin Cell Biol 4:1008–1016, 1992

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 40 Years of RAS—A Historic Overview;Genes;2021-05-01

2. Farnesyl Transferase Inhibitors as Potential Anticancer Agents;Mini-Reviews in Medicinal Chemistry;2018-10-12

3. Development of Substrate-Derived Sirtuin Inhibitors with Potential Anticancer Activity;ChemMedChem;2017-09-25

4. In Vitro and In Vivo Antiplasmodial Activities of Risedronate and Its Interference with Protein Prenylation in Plasmodium falciparum;Antimicrobial Agents and Chemotherapy;2011-05

5. Rho GTPases: Promising Cellular Targets for Novel Anticancer Drugs;Current Cancer Drug Targets;2006-02-01